Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lyme disease: point/counterpoint.

Raphael B Stricker1, Andrew Lautin, Joseph J Burrascano

  • 1California Pacific Medical Center , 450 Sutter Street, Suite 1504, San Francisco, CA 94108, USA. rstricker@usmamed.com

Expert Review of Anti-Infective Therapy
|May 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data.

Healthcare (Basel, Switzerland)·2025
Same author

Recombinant protein immunoblots for differential diagnosis of tick-borne relapsing fever and Lyme disease.

Journal of vector borne diseases·2024
Same author

Does Biological Sex Matter in Lyme Disease? The Need for Sex-Disaggregated Data in Persistent Illness.

International journal of general medicine·2023
Same author

Role of hydroxychloroquine in multidrug treatment of COVID-19.

Reviews in cardiovascular medicine·2021
Same author

Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis.

Journal of infection and public health·2021
Same author

Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease.

Clinical, cosmetic and investigational dermatology·2021

Lyme disease treatment faces challenges due to complex infections and coinfections. Effective, prolonged combination therapy may be needed for persistent Borrelia burgdorferi symptoms.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Lyme disease is a growing public health concern with complex diagnosis and treatment.
  • Borrelia burgdorferi, the causative agent, presents challenges due to its affinity for multiple cell types and nonreplicating forms.
  • Tickborne coinfections (Babesia, Anaplasma, Ehrlichia, Bartonella) complicate Lyme disease management.

Purpose of the Study:

  • To highlight the clinical and pathophysiological complexities of Lyme disease.
  • To discuss the barriers in reliable diagnosis and effective treatment.
  • To explore newer approaches for managing persistent Lyme disease symptoms.

Main Methods:

  • Review of current understanding of Borrelia burgdorferi pathophysiology.
  • Analysis of challenges posed by tickborne coinfections.

Related Experiment Videos

  • Discussion of limitations in current antibiotic regimens.

    • Main Results:

    • Absence of a clear therapeutic endpoint for Borrelia burgdorferi infection.
    • Coinfections significantly complicate disease course and treatment.
    • Nonreplicating spirochete forms contribute to persistent infections and treatment failure.

    Conclusions:

    • Newer Lyme disease treatment strategies must address clinical complexity and coinfections.
    • Prolonged combination antibiotic therapy may be necessary for persistent symptoms.
    • Optimal antibiotic regimens for chronic Lyme disease require further determination.